Skip to content Skip to sidebar Skip to footer
Disinflation Wins, Tech Whimpers: A Soft Landing With Hard Questions for Wall Street – July 16, 2026 -( $HPP $INTG $VIX $YSG Rise!)
U.S. markets closed broadly lower on Thursday, July 16, 2026, with a decisive risk‑off tone as investors rotated out of high‑beta growth and precious metals while volatility climbed.Market close: indices and risk sentimentThe S&P 500 (^GSPC) finished at 7,533.77, down 38.63 points…
China’s Robot Economy Is Already Here, and Beauty Is Learning the Same Lesson -( $YSG )
The BBC’s recent look at Geek+ makes one point very clearly: the future of retail is being built in warehouses, not just in boardrooms. At Geek+’s factory in Hefei, fleets of autonomous robots are assembled and tested before heading to warehouses around…
Investor-focused graphic showing Yatsen Holding (NYSE: YSG) ahead of its September 2 second-quarter earnings report, featuring rising earnings and growth charts, premium skincare products, and the company’s Sephora China partnership as key catalysts.
Yatsen Heads Into Sept. 2 Q2 Earnings With Sephora China and Skincare Growth in Focus -( $YSG $LVMUY )
Yatsen Holding Limited (NYSE: YSG) is approaching a consequential earnings date with a more compelling narrative than the market may be pricing in: a China beauty platform shifting from online color-cosmetics challenger to science-led, premium omnichannel operator. Its partnership to place Perfect Diary…
Yatsen Holding Limited (NYSE: YSG) Q2 2026 earnings infographic highlighting 40.4% year-over-year skincare revenue growth, product imagery flowing along an upward teal arrow, a revenue bar chart, and a strategic timeline from Q1 2026 through Q3 2026 and beyond.
Yatsen ( NYSE: $YSG ) Q2 2026 Earnings: Skincare Revenue Surges 40.4% as Transformation Accelerates
Yatsen Holding Limited (NYSE: YSG) delivered the sort of quarter that can make a turnaround investor sit up straighter: reported revenue grew, its strategically important skincare operation accelerated sharply, and the company is increasingly built around clinical and premium brands rather than a…